Discovery of natural mouse serum derived HIV-1 entry inhibitor(s)

被引：0

作者：

Wei, M. ^{[1
]}

Chen, Y. ^{[2
]}

Xi, J. ^{[1
]}

Ru, S. ^{[1
]}

Ji, M. ^{[1
]}

Zhang, D. ^{[1
]}

Fang, Q. ^{[3
]}

Tang, B. ^{[1
]}

机构：

[1] Bengbu Med Coll, Sch Life Sci, Inst Neurobiol, Anhui Key Lab Infect & Immun, Bengbu 233030, Peoples R China

[2] Univ Arizona, Dept Pharmacol, Coll Med, Tucson, AZ 85724 USA

[3] Bengbu Med Coll, Dept Microbiol & Parasitol, Anhui Key Lab Infect & Immun, Bengbu 233030, Peoples R China

来源：

ACTA VIROLOGICA | 2016年 / 60卷 / 04期

关键词：

HIV-1; entry; natural inhibitor; mouse serum; VIRUS; FUSION; PEPTIDE; POTENT; GP41; REPLICATION; ENFUVIRTIDE; RESISTANCE; AGONIST; CELLS;

D O I：

10.4149/av_2016_04_404

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Among rationally designed human immunodeficiency virus 1 (HIV-1) inhibitors, diverse natural factors have showed as potent anti-HIV activity in human blood. We have discovered that the boiled supernatant of healthy mouse serum could suppress HIV-1 entry, and exhibited reduced inhibitory activity after trypsin digestion. Further analysis demonstrated that only the fraction containing 10-25 K proteins could inhibit HIV-1 mediated cell-cell fusion. These results suggest that the 10-25 K protein(s) is novel natural HIV-1 entry inhibitor(s). Our findings provide important information about novel natural HIV entry inhibitors in mouse serum.

引用

页码：404 / 409

页数：6

共 50 条

[1] Discovery of VIRIP - a natural HIV entry inhibitor
Poveda, Eva
AIDS REVIEWS, 2007, 9 (02) : 126 - 126
[2] Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide
Muench, Jan
Staendker, Ludger
Adermann, Knut
Schuz, Axel
Schindler, Michael
Chinnadurai, Raghavan
Poehlmann, Stefan
Chaipan, Chawaree
Biet, Thorsten
Peters, Thomas
Meyer, Bernd
Wilhelm, Dennis
Lu, Hong
Jing, Weiguo
Jiang, Shibo
Forssmann, Wolf-Georg
Kirchhoff, Frank
CELL, 2007, 129 (02) : 263 - 275
[3] HIV-1 entry inhibitor entrances
Kuhmann, SE
Moore, JP
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (03) : 117 - 120
[4] A mouse model for HIV-1 entry
Pietzsch, John
Gruell, Henning
Bournazos, Stylianos
Donovan, Bridget M.
Klein, Florian
Diskin, Ron
Seaman, Michael S.
Bjorkman, Pamela J.
Ravetch, Jeffrey V.
Ploss, Alexander
Nussenzweig, Michel C.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (39) : 15859 - 15864
[5] Natural barrier to HIV-1 entry
Monica Hoyos Flight
Nature Reviews Drug Discovery, 2007, 6 : 436 - 436
[6] Natural barrier to HIV-1 entry
Flight, Monica Hoyos
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (06) : 436 - 436
[7] Protein design of an HIV-1 entry inhibitor
Root, MJ
Kay, MS
Kim, PS
SCIENCE, 2001, 291 (5505) : 884 - 888
[8] Structure of a designed HIV-1 entry inhibitor
Van Train, KM
Pace, HC
Paul, S
Brenner, C
Root, MJ
BIOPHYSICAL JOURNAL, 2003, 84 (02) : 175A - 175A
[9] HIV-1 entry - an expanding portal for drug discovery
Blair, WS
Lin, PF
Meanwell, NA
Wallace, OB
DRUG DISCOVERY TODAY, 2000, 5 (05) : 183 - 194
[10] HIV-1 cell entry and advances in viral entry inhibitor therapy
Cooley, LA
Lewin, SR
JOURNAL OF CLINICAL VIROLOGY, 2003, 26 (02) : 121 - 132

← 1 2 3 4 5 →